MAPT and Alzheimer disease: Moreover, in in vivo studies, oral administration of curcumin has resulted in the inhibition of Aβ oligomerization, Aβ deposition, and tau phosphorylation in the brains of AD animal models, as well as led to the improvements in behavioral impairment in animal models (12).